This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Novozymes A/s. Active years: 2001-2003.
Location History:
- Skodsborg, DK (2001 - 2003)
- Frorup, DK (2003)
Company Filing History:
Years Active: 2001-2003
Title: Lisbeth Hedegaard Hoeck: Innovator in Enzyme Technology
Introduction
Lisbeth Hedegaard Hoeck is a prominent inventor based in Frorup, Denmark. She has made significant contributions to the field of enzyme technology, particularly through her work at Novozymes A/S. With a total of 4 patents to her name, she has established herself as a key figure in the development of innovative solutions in biotechnology.
Latest Patents
Lisbeth's latest patents include groundbreaking inventions such as nucleic acid sequences encoding alkaline alpha-amylases. This invention relates to isolated nucleic acid sequences that encode polypeptides with alpha-amylase activity, derived from Bacillus. The patent also covers nucleic acid constructs, vectors, and host cells that incorporate these sequences, along with methods for producing and utilizing the polypeptides. Another notable patent is for a 2,6-β-D-fructan hydrolase enzyme and processes for its application. This invention involves isolated polypeptides with 2,6-β-D-fructan hydrolase activity and the corresponding nucleic acid sequences. It also includes constructs, vectors, and host cells that contain these sequences, as well as methods for their production and use.
Career Highlights
Lisbeth has built a successful career at Novozymes A/S, a leading company in the field of enzyme production. Her work has not only advanced the scientific understanding of enzyme functions but has also contributed to practical applications in various industries.
Collaborations
Throughout her career, Lisbeth has collaborated with esteemed colleagues, including Helle Outtrup and Torben Vedel Borchert. These partnerships have fostered innovation and have been instrumental in the development of her patented technologies.
Conclusion
Lisbeth Hedegaard Hoeck's contributions to enzyme technology through her patents and work at Novozymes A/S highlight her role as a leading inventor in the field. Her innovative approaches continue to influence the biotechnology landscape.